Denali Therapeutics
DNLI
DNLI
216 hedge funds and large institutions have $4.59B invested in Denali Therapeutics in 2021 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 78 increasing their positions, 69 reducing their positions, and 26 closing their positions.
Holders
216
Holders Change
+12
Holders Change %
+5.88%
% of All Funds
3.8%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
41
Increased
78
Reduced
69
Closed
26
Calls
$8.56M
Puts
$4.85M
Net Calls
+$3.71M
Net Calls Change
-$19.8M
Top Buyers
| 1 |
1
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$742M |
| 2 |
CS
2
Credit Suisse
Zurich,
Switzerland
|
$112M |
| 3 |
CC
3
Casdin Capital
New York
|
$91.9M |
| 4 |
4
Renaissance Technologies
New York
|
$15.2M |
| 5 |
5
Morgan Stanley
New York
|
$26.4M |
